Open Access DOI:10.23937/2378-3419/1410139
Assessment of Serum Selenium and Zinc in Esophageal Cancer Patients
Mansoora Akhtar, MD, Nazir Ahmad Khan, MD, Syed Mudasir Jan, MD, Arshad Manzoor, MD, Nazir Ahmad Dar, MSc, M Maqbool Lone, MD
Article Type: Original Article | First Published: June 29, 2020
Oesophageal cancer represents a major health problem, continues to have very poor prognosis despite advances in its management that include improved surgical technique, neoadjuvant and adjuvant therapy as there seems to be little project for early detection and treatment, a better understanding of the risk factors may suggest opportunity for its primary prevention. A total of 200 cases of histology confirmed carcinoma oesophagus (study group) and 200 case of healthy individual (control group) we...
Open Access DOI:10.23937/2378-3419/1410138
Solitary Brain Metastasis in Low-Risk Prostate Cancer - A Case Report
Sonha Nguyen, Sameer Shah, Neil Dudheker and Vishal Ranpura
Article Type: Case Report | First Published: June 04, 2020
Adenocarcinoma of prostate is the most common cancer affecting men in United States. The most common sites of prostate cancer metastasis are to bone and pelvic lymph nodes. Brain metastases are rare and reported in less than 1% of prostate cancer patients. Among the patients with brain metastasis, most of them had concurrent systemic disease involvement, such as: bone, lymph node, liver and/ or lung metastasis. We report a case of patient with low risk prostate cancer, stage IV B, with well cont...
Open Access DOI:10.23937/2378-3419/1410137
Women's Personal and Life-Style Characteristics as Related to Molecular Genetic Changes within Their Uterine Cancers
Peter Zauber, MD, Thad R Denehy, MD, Robert R Taylor, MD, Stephen Marotta, PhD3Marlene Sabbath Solitare, PhD and Patrick Hilden, MS
Article Type: Review Article | First Published: May 22, 2020
The histopathology and molecular genetics of endometrial cancer have been extensively studied, and they continue to receive attention and new interpretations. However, few studies have evaluated patients’ personal and clinical characteristics, or family history, with respect to the tumors’ molecular changes. The aim of our study was to evaluate the personal and familial information of patients with respect to several molecular genetic findings of their endometrial cancers....
